WallStreetZenWallStreetZen

NASDAQ: BMEA
Biomea Fusion Inc Stock Forecast, Predictions & Price Target

Analyst price target for BMEA

Based on 5 analysts offering 12 month price targets for Biomea Fusion Inc.
Min Forecast
$14.00+33.72%
Avg Forecast
$55.80+432.95%
Max Forecast
$90.00+759.6%

Should I buy or sell BMEA stock?

Based on 5 analysts offering ratings for Biomea Fusion Inc.
Buy
Strong Buy
2 analysts 40%
Buy
2 analysts 40%
Hold
1 analysts 20%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their BMEA stock forecasts and price targets.

BMEA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-03
lockedlocked$00.00+00.00%2024-04-02
lockedlocked$00.00+00.00%2024-04-01
lockedlocked$00.00+00.00%2024-04-01
lockedlocked$00.00+00.00%2023-12-08

1 of 1

Forecast return on equity

Is BMEA forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.16%

Forecast return on assets

Is BMEA forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

BMEA revenue forecast

What is BMEA's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$10.0M
Avg 2 year Forecast
$15.0M
Avg 3 year Forecast
$10.8M

BMEA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
BMEA$10.47$55.80+432.95%Buy
CBUS$15.54$25.00+60.88%Buy
REPL$6.15$37.67+512.47%Strong Buy
PEPG$11.70$20.00+70.94%Buy
ADPT$2.61$6.00+129.89%Strong Buy

Biomea Fusion Stock Forecast FAQ

Is Biomea Fusion Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: BMEA) stock is to Buy BMEA stock.

Out of 5 analysts, 2 (40%) are recommending BMEA as a Strong Buy, 2 (40%) are recommending BMEA as a Buy, 1 (20%) are recommending BMEA as a Hold, 0 (0%) are recommending BMEA as a Sell, and 0 (0%) are recommending BMEA as a Strong Sell.

If you're new to stock investing, here's how to buy Biomea Fusion stock.

What is BMEA's revenue growth forecast for 2024-2026?

(NASDAQ: BMEA) Biomea Fusion's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.04%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.92%.

Biomea Fusion's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast BMEA's revenue for 2024 to be $358,893,600, with the lowest BMEA revenue forecast at $358,893,600, and the highest BMEA revenue forecast at $358,893,600. On average, 1 Wall Street analysts forecast BMEA's revenue for 2025 to be $538,340,400, with the lowest BMEA revenue forecast at $538,340,400, and the highest BMEA revenue forecast at $538,340,400.

In 2026, BMEA is forecast to generate $388,322,875 in revenue, with the lowest revenue forecast at $238,305,350 and the highest revenue forecast at $538,340,400.

What is BMEA's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: BMEA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is BMEA's Price Target?

According to 5 Wall Street analysts that have issued a 1 year BMEA price target, the average BMEA price target is $55.80, with the highest BMEA stock price forecast at $90.00 and the lowest BMEA stock price forecast at $14.00.

On average, Wall Street analysts predict that Biomea Fusion's share price could reach $55.80 by Apr 3, 2025. The average Biomea Fusion stock price prediction forecasts a potential upside of 432.95% from the current BMEA share price of $10.47.

What is BMEA's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: BMEA) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.